Home/Filings/4/0001562180-22-004174
4//SEC Filing

Glanzman Robert 4

Accession 0001562180-22-004174

CIK 0001822791other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 8:34 AM ET

Size

5.2 KB

Accession

0001562180-22-004174

Insider Transaction Report

Form 4
Period: 2022-05-16
Glanzman Robert
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2022-05-16$2.03/sh4,717$9,57610,564 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman.

Issuer

Clene Inc.

CIK 0001822791

Entity typeother

Related Parties

1
  • filerCIK 0001835428

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 8:34 AM ET
Size
5.2 KB